Certis Oncology Solutions
Research, 5626 Oberlin Dr, San Diego, California, 92121, United States, 11-50 Employees
Who is CERTIS ONCOLOGY SOLUTIONS
Certis Oncology Solutions is a life science technology company with a mission to realize the promise of precision oncology. Our product is Oncology IntelligenceTM highly predictive therap...
Read More
-
Headquarters: 5626 Oberlin Dr, San Diego, California, 92121, United States
-
Date Founded: 2016
-
Employees: 11-50
-
Revenue: $1 Billion and Over
-
Active Tech Stack: See technologies
SIC Code: 
Does something look wrong? Fix it. | View contact records from CERTIS ONCOLOGY SOLUTIONS
Certis Oncology Solutions Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Certis Oncology Solutions
Answer: Certis Oncology Solutions's headquarters are located at 5626 Oberlin Dr, San Diego, California, 92121, United States
Answer: Certis Oncology Solutions's official website is https://certisoncologysolutions.com
Answer: Certis Oncology Solutions's revenue is $1 Billion and Over
Answer: Certis Oncology Solutions's SIC: 2836
Answer: Certis Oncology Solutions's NAICS: 541714
Answer: Certis Oncology Solutions has 11-50 employees
Answer: Certis Oncology Solutions is in Research
Answer: Certis Oncology Solutions contact info: Phone number: Website: https://certisoncologysolutions.com
Answer: Certis Oncology Solutions is a life science technology company with a mission to realize the promise of precision oncology. Our product is Oncology IntelligenceTM highly predictive therapeutic response data derived from proprietary biological models of cancer. We apply these models to machine learning and AI-enhanced predictive algorithms, the development of the next generation of targeted cancer therapeutics, and functional precision medicine. Established in 2016, Certis began its journey in functional precision oncology, helping cancer patients and their oncologists through YourPDXTM testing. ACCELERATING THE DEVELOPMENT OF NEW CANCER THERAPIES Certis partners with therapeutic developers to help close the problematic translational gap between preclinical studies and clinical trials. Through clinically relevant, well-characterized and annotated cancer models, advanced imaging technology, including x-ray irradiation with image-guided radiation therapy, and thoughtfully designed custom studies, our proprietary platform can bring greater certainty to go/no-go drug development decisions. We are committed to providing translationally relevant preclinical models to drug developers for efficient and effective transition into the clinic. Learn more about our preclinical oncology services.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month